[1]
S. UDHAYAVANI et al. 2018. Method development and validation of Canagliflozin in human plasma by liquid chromatography tandem mass spectrometry (LC-MS/MS). International Journal of Pharma and Bio Sciences. 9, 2 (Jun. 2018), 140–147. DOI:https://doi.org/10.22376/ijpbs.2018.9.2.p140-147.